Emily Carterson

Emily Carterson reports on US companies, startups, corporate strategy, and mergers and acquisitions. She provides clear insights into US business trends so you can identify opportunities and manage risks.
Medicare finalizes a rate hike for private insurers — and health stocks get a boostThe increase, far above a near-flat January proposal, adds more than $13 billion in payments to Medicare Advantage plans
Business

Medicare signs off on bigger payments to private insurers: health stocks jump

States can’t regulate Kalshi, federal court saysThe ruling was the first by a federal appeals court to weigh in on whether states can regulate prediction market platforms
Business

Kalshi wins: federal appeals court rules states cannot police prediction markets

Novo Nordisk launches a new Wegovy subscription as it trails Eli Lilly in the weight loss drug raceThe program launched through telehealth providers Ro, WeightWatchers, and LifeMD, with Hims & Hers and Sesame to follow
Business

Wegovy subscription aims to shrink Eli Lilly’s lead: telehealth partners begin rollout

Novo Nordisk says its Wegovy pill beats Eli Lilly's rival on weight lossA cross-trial comparison showed oral semaglutide produced three more percentage points of weight loss and fewer patients dropping out due to side effects
Business

Novo Nordisk’s Wegovy pill bests Eli Lilly rival: delivers 3 percentage points more weight loss

FDA flags 3.1 million store-brand eye drops recalled over sterility concernsNo injuries have been reported, but regulators say the manufacturer can't guarantee the products are free of bacteria or fungi
Business

FDA recalls 3.1 million store-brand eye drops: sterility may be compromised

Novo Nordisk says Wegovy shows greater weight loss than Eli Lilly's rival pillA cross-trial comparison shows Novo's oral semaglutide produced 3.2 percentage points more weight loss than Foundayo, with Eli Lilly's drug seeing significantly higher dropout rates due to side effects.
Business

Weight loss: Novo Nordisk semaglutide beats Lilly pill by 3.2 pts, higher dropouts from side effects

McCormick is buying Unilever's food business in a $45 billion dealThe cash-and-stock transaction will create a combined company with roughly $20 billion in annual revenue
Business

McCormick agrees $45 billion takeover of Unilever food arm: combined revenue about $20 billion

Starbucks says it will give baristas bonusesThe quarterly bonus program, set to launch in July, is the chain's most significant frontline pay boost under CEO Brian Niccol
Business

Starbucks bonuses for baristas start in July: biggest frontline pay boost under CEO Niccol

Wawa recalls 4 bottled drinks in 5 states over undeclared milk allergenA temporary equipment issue may have introduced milk into beverages that do not list it as an ingredient
Business

Wawa recall affects four bottled beverages in five states: possible milk contamination

Holganix CTO explains how its Bio 800 product restores life to soilHolganix Chief Technology Officer Austin Hausmann explains how its Bio 800 product restores life to soil
Business

Bio 800 revives soil health: Holganix CTO breaks down the science

Gap brands will soon let shoppers buy directly from GeminiGap is also rolling out AI-powered size recommendations, making it the first big-name fashion brand to offer in-app Gemini checkout
Business

Gap launches Gemini checkout and AI size picks: first major fashion brand to enable in-app buying

Sony to increase PS5 prices by as much as $150
Business

PS5 price hike could add up to $150: what buyers need to know

123…7 Next